Episode 201: AMD Drug Updates with Dr. Allen Ho, including Gene Therapy

Dr. Allen Ho of Wills Eye Hospital rejoins the program to discuss updates in pharmacotherapy for macular degeneration, including gene therapy applications.

Want to be on the podcast? Now is your chance! Vit-Buckle Society is looking for videos to be presented on the podium during the Complications session of the Annual Meeting in Miami March 26-28 2020. Videos can be identifying or anonymous but should include text descriptions and be 1-4 minutes in length. The top five entries will be invited to come on the podcast for a one-on-one interview discussing the case. Submit entries now to paulapecen@gmail.com or mklufas@gmail.com

You can now claim CME credits via the AAO website. Visit https://www.aao.org/browse-multimedia?filter=Audio&sub=ONE.ContentTypes.Audio.

Financial Disclosures:
Dr. Sridhar has received consulting fees from Alcon, Alimera Science, and Oxurion. Dr. Ho's relevant financial disclosures include consulting fees for Iveric, Johnson & Johnson, and RegenexBio.